These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 21763761

  • 21. A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.
    Lee PH, McNutt RW, Chang KJ.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):883-7. PubMed ID: 8246163
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain.
    Jhaveri MD, Richardson D, Robinson I, Garle MJ, Patel A, Sun Y, Sagar DR, Bennett AJ, Alexander SP, Kendall DA, Barrett DA, Chapman V.
    Neuropharmacology; 2008 Jul; 55(1):85-93. PubMed ID: 18534634
    [Abstract] [Full Text] [Related]

  • 23. Effect of agmatine on brain L-citrulline production during morphine withdrawal in rats: a microdialysis study in nucleus accumbens.
    Yananli H, Gören MZ, Berkman K, Aricioğlu F.
    Brain Res; 2007 Feb 09; 1132(1):51-8. PubMed ID: 17182008
    [Abstract] [Full Text] [Related]

  • 24. The effects of a 5-HT7 receptor agonist and antagonist on morphine withdrawal syndrome in mice.
    Shahidi S, Hashemi-Firouzi N.
    Neurosci Lett; 2014 Aug 22; 578():27-32. PubMed ID: 24954075
    [Abstract] [Full Text] [Related]

  • 25. Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats.
    Azizi H, Mirnajafi-Zadeh J, Rohampour K, Semnanian S.
    Neurosci Lett; 2010 Oct 04; 482(3):255-9. PubMed ID: 20667500
    [Abstract] [Full Text] [Related]

  • 26. The C-terminal amidated analogue of the substance P (SP) fragment SP(1-7) attenuates the expression of naloxone-precipitated withdrawal in morphine dependent rats.
    Zhou Q, Carlsson A, Botros M, Fransson R, Sandström A, Gordh T, Hallberg M, Nyberg F.
    Peptides; 2009 Dec 04; 30(12):2418-22. PubMed ID: 19686790
    [Abstract] [Full Text] [Related]

  • 27. Examining the effect of the CaMKII inhibitor administration in the locus coeruleus on the naloxone-precipitated morphine withdrawal signs in rats.
    Navidhamidi M, Semnanian S, Javan M, Goudarzvand M, Rohampour K, Azizi H.
    Behav Brain Res; 2012 Jan 15; 226(2):440-4. PubMed ID: 22004981
    [Abstract] [Full Text] [Related]

  • 28. Suppressive effects by cysteine protease inhibitors on naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Tan-No K, Sato T, Shimoda M, Nakagawasai O, Niijima F, Kawamura S, Furuta S, Sato T, Satoh S, Silberring J, Terenius L, Tadano T.
    Neuropeptides; 2010 Jun 15; 44(3):279-83. PubMed ID: 20189644
    [Abstract] [Full Text] [Related]

  • 29. Influence of sweet tasting solutions on opioid withdrawal.
    Jain R, Mukherjee K, Singh R.
    Brain Res Bull; 2004 Dec 15; 64(4):319-22. PubMed ID: 15561466
    [Abstract] [Full Text] [Related]

  • 30. [A method for the quantitative assessment of the withdrawal syndrome in morphine-dependent rats].
    Sudakov SK, Borisova EV, Rusakov DIu.
    Eksp Klin Farmakol; 1994 Dec 15; 57(2):60-3. PubMed ID: 8205055
    [Abstract] [Full Text] [Related]

  • 31. Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice.
    Gamage TF, Ignatowska-Jankowska BM, Muldoon PP, Cravatt BF, Damaj MI, Lichtman AH.
    Drug Alcohol Depend; 2015 Jan 01; 146():7-16. PubMed ID: 25479915
    [Abstract] [Full Text] [Related]

  • 32. Intracoerulear microinjection of orexin-A induces morphine withdrawal-like signs in rats.
    Ghaemi-Jandabi M, Azizi H, Ahmadi-Soleimani SM, Semnanian S.
    Brain Res Bull; 2017 Apr 01; 130():107-111. PubMed ID: 28093335
    [Abstract] [Full Text] [Related]

  • 33. Pharmacological modulation of geranylgeranyltransferase and farnesyltransferase attenuates opioid withdrawal in vivo and in vitro.
    Rehni AK, Singh TG.
    Neuropharmacology; 2013 Aug 01; 71():19-26. PubMed ID: 23415632
    [Abstract] [Full Text] [Related]

  • 34. Persistent effects of the orexin-1 receptor antagonist SB-334867 on naloxone precipitated morphine withdrawal symptoms and nociceptive behaviors in morphine dependent rats.
    Kourosh-Arami M, Joghataei MT, Komaki A, Gholami M, Najafi Z, Lavaie M.
    Int J Neurosci; 2022 Jan 01; 132(1):67-76. PubMed ID: 32746675
    [Abstract] [Full Text] [Related]

  • 35. Duloxetine attenuated morphine withdrawal syndrome in the rat.
    Charkhpour M, Jafari RM, Ghavimi H, Ghanbarzadeh S, Parvizpur A.
    Drug Res (Stuttg); 2014 Aug 01; 64(8):393-8. PubMed ID: 24265113
    [Abstract] [Full Text] [Related]

  • 36. Acute administration of pioglitazone attenuates morphine withdrawal syndrome in rat: a novel role of pioglitazone.
    Ghavimi H, Azarfardian A, Maleki-Dizaji N, Hassanzadeh K, Ghanbarzadeh S, Charkhpour M.
    Drug Res (Stuttg); 2015 Mar 01; 65(3):113-8. PubMed ID: 24504689
    [Abstract] [Full Text] [Related]

  • 37. The effects of different 4-aminopyridine and morphine combinations on the intensity of morphine abstinence.
    Koyuncuoğlu H, Nurten A, Enginar N, Ozerman B, Kara I.
    Pharmacol Res; 2001 Mar 01; 43(3):245-50. PubMed ID: 11401416
    [Abstract] [Full Text] [Related]

  • 38. Naloxone-precipitated withdrawal as a function of the morphine-naloxone interval.
    Linseman MA.
    Psychopharmacology (Berl); 1977 Oct 20; 54(2):159-64. PubMed ID: 412210
    [Abstract] [Full Text] [Related]

  • 39. Acute naloxone-precipitated morphine withdrawal elicits nausea-like somatic behaviors in rats in a manner suppressed by N-oleoylglycine.
    Rock EM, Ayoub SM, Limebeer CL, Gene A, Wills KL, DeVuono MV, Smoum R, Di Marzo V, Lichtman AH, Mechoulam R, Parker LA.
    Psychopharmacology (Berl); 2020 Feb 20; 237(2):375-384. PubMed ID: 31712968
    [Abstract] [Full Text] [Related]

  • 40. Desmopressin accelerates the rate of urinary morphine excretion and attenuates withdrawal symptoms in rats.
    Saboory E, Ghazizadeh V, Heshmatian B, Khademansari MH.
    Psychiatry Clin Neurosci; 2012 Dec 20; 66(7):594-601. PubMed ID: 23252926
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.